This inventor holds 1 USPTO granted patent. Top assignee: Wakamoto Pharmaceutical Co., Ltd.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: **Masanobu Kirita: Pioneering Innovations in Antibacterial Pharmaceutical Compositions**
Introduction
Masanobu Kirita, an accomplished inventor located in Chiba, Japan, has made significant contributions to the field of pharmaceuticals. With a particular focus on the development of aqueous pharmaceutical compositions, he aims to enhance the efficacy and stability of antibacterial agents.
Latest Patents
Kirita holds a patent for "Aqueous pharmaceutical compositions," which addresses the need for antibacterial solutions that maintain low gelation temperatures while ensuring prolonged retention at the administration site. This innovation is crucial in providing effective delivery of new quinolone antibacterial agents, such as ofloxacin, by facilitating rapid viscosity increases post-administration. The patent highlights Kirita's commitment to improving the availability and effectiveness of pharmaceutical agents in clinical settings.
Career Highlights
Masanobu Kirita's work has been aligned with Wakamoto Pharmaceutical Co., Ltd., a notable company in the pharmaceutical industry. His career has been marked by a dedication to research and development, focusing on innovative solutions that address critical needs in healthcare.
Collaborations
Throughout his career, Kirita has collaborated with esteemed colleagues, including Hidekazu Suzuki and Takahiro Wada. These partnerships have been instrumental in fostering an environment of creativity and innovation, driving advancements in pharmaceutical compositions.
Conclusion
Masanobu Kirita's inventive spirit and dedication to improving pharmaceutical compositions exemplify the vital role of inventors in the healthcare industry. His contributions not only enhance the effectiveness of antibacterial treatments but also pave the way for future innovations in the field. With his ongoing efforts, the future of pharmaceutical advancements looks promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
